Recent advancements in new tracers from first-in-human studies

Area of Science:

• Nuclear medicine
• Molecular imaging
• Radiochemistry

Background:

• Positison emission tomography (PET) tracers are crucial for diagnosing and monitoring neurological and oncological conditions.
• Recent innovations have expanded the utility of PET imaging in these fields.

Purpose of the Study:

• To provide an overview of newly developed PET tracers.
• To highlight their applications in neurology and oncology.

Main Methods:

• Review of recent advancements in PET tracer development.
• Focus on tracers for neuroinflammation, neurotransmitter systems, and various cancers.

Main Results:

• Development of novel tracers targeting PD-L1, PSMA, HER2, Claudin 18, and glutamine.
• Tracers for assessing cancer metabolism and therapy efficacy.
• Emerging applications in adrenal imaging, amyloidosis, and HIV infection.

Conclusions:

• Advanced PET tracers offer enhanced visualization of disease processes.
• These tracers are vital for personalized medicine in neurology and oncology.
• Continued development promises further improvements in diagnostic and therapeutic strategies.